Phathom Pharmaceuticals: Funding, Investors & Team (Oct 2026)
A biopharmaceutical business called Phathom Pharmaceuticals is dedicated to changing the way GI (gastrointestinal) disorders associated with acid are treated. We are a group of highly motivated healthcare experts with a mission to meet patients' unmet needs and enhance their quality of life. We try to foster a sense of inclusion and belonging by making sure all views are heard, holding ourselves accountable to be just and equitable, and genuinely supporting the individuals and communities affected by our work. We are seeking self-driven, inventive problem solvers that would enjoy working in a fast-paced start-up environment and advancing our development.
Phathom Pharmaceuticals has raised $622M across 5 funding rounds on record, the most recent an undisclosed round of $130M announced in Jan 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Phathom Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Phathom Pharmaceuticals Funding Rounds
Phathom Pharmaceuticals raised $200M in a Post-IPO Debt announced in Sep 2021.
1.2 years later, an undisclosed round of $40.0M was announced in Nov 2022.
6 months later, an undisclosed round of $122M was announced in May 2023.
1.3 years later, an undisclosed round of $130M was announced in Aug 2024.
1.4 years later, an undisclosed round of $130M was announced in Jan 2026.
Phathom Pharmaceuticals Founders and Leadership Team
Contact details for the Phathom Pharmaceuticals team: 1 of 3 have an email address on file.
Start 14-day free trial →Phathom Pharmaceuticals Funding Compared to Other Biotechnology Startups
Phathom Pharmaceuticals' latest round of $130M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Phathom Pharmaceuticals in Biotechnology and Florham Park
Companies Similar to Phathom Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Phathom Pharmaceuticals Funding FAQs
What does Phathom Pharmaceuticals do?
A biopharmaceutical business called Phathom Pharmaceuticals is dedicated to changing the way GI (gastrointestinal) disorders associated with acid are treated. We are a group of highly motivated healthcare experts with a mission to meet patients' unmet needs and enhance their quality of life. We try to foster a sense of inclusion and belonging by making sure all views are heard, holding ourselves accountable to be just and equitable, and genuinely supporting the individuals and communities affected by our work. We are seeking self-driven, inventive problem solvers that would enjoy working in a fast-paced start-up environment and advancing our development.
How much funding has Phathom Pharmaceuticals raised?
Phathom Pharmaceuticals has raised $622M across 5 rounds on record. The most recent is an undisclosed round of $130M announced in Jan 2026.
When did Phathom Pharmaceuticals last raise funding?
Phathom Pharmaceuticals' most recent funding round on record is an undisclosed round of $130M, announced in Jan 2026.
Who founded Phathom Pharmaceuticals?
FundedIQ lists Azmi Nabulsi (Founder), Roger Ulrich (Founder) at Phathom Pharmaceuticals.
Who is the CEO of Phathom Pharmaceuticals?
Terrie Curran is listed as CEO at Phathom Pharmaceuticals.
Where is Phathom Pharmaceuticals headquartered?
Phathom Pharmaceuticals is based in Florham Park, New Jersey, United States.
How many employees does Phathom Pharmaceuticals have?
Phathom Pharmaceuticals is in the 101-250 employee band.
How does Phathom Pharmaceuticals' funding compare to other Biotechnology startups?
Phathom Pharmaceuticals' latest round of $130M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Phathom Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Phathom Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.